DOI QR코드

DOI QR Code

Comparisons of Effects of Biman-tang according to Administration Period in Childhood Obesity

비만환아에서 복약기간에 따른 비만탕의 치료효과 비교연구

  • Lim, Youngkwern (Dept. of Herbology, College of Korean Medicine, Kyung Hee University) ;
  • Min, Seorim (Dept. of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Heeman (Dept. of Herbology, College of Korean Medicine, Kyung Hee University) ;
  • Hur, Kwang-Wook (Dept. of Herbology, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Hoon (Gangnam Inuri Korean Medical Clinic) ;
  • Lee, Jinsoo (Dept. of Korean Internal Medicine, Dongseo Yunghap Hospital) ;
  • Kim, Hocheol (Dept. of Herbology, College of Korean Medicine, Kyung Hee University) ;
  • Park, Jae-Woo (Dept. of Internal Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Hi-Joon (Dept. of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee University)
  • 임영권 (경희대학교 한의과대학 본초학교실) ;
  • 민서림 (경희대학교 한의과대학 경혈학교실) ;
  • 김희만 (경희대학교 한의과대학 본초학교실) ;
  • 허광욱 (경희대학교 한의과대학 본초학교실) ;
  • 이훈 (강남 아이누리 한의원) ;
  • 이진수 (동서융합병원 한방내과) ;
  • 김호철 (경희대학교 한의과대학 본초학교실) ;
  • 박재우 (경희대학교 한의과대학 내과학교실) ;
  • 박히준 (경희대학교 한의과대학 경혈학교실)
  • Received : 2013.10.25
  • Accepted : 2013.11.14
  • Published : 2013.11.30

Abstract

Objectives The purpose of this study is to investigate the safety and effect of Biman-tang (BMT) on two different administration periods in the treatment of childhood overweight and obesity. Methods In retrospective study, 39 overweight and obese ($85^{th}$ percentile ${\leq}$ Body Mass Index (BMI)) children were treated with BMT from January 2006 to April 2013 at Korean Medical Clinic in Suwon, Korea. The primary outcomes were the changes in BMI and Obesity Index (OI) from baseline to the treatment groups. Secondary outcomes included the changes in height, weight and safety of the medicine. Comparisons of BMI, OI, height and weight between the short-period (SP) treatment group and the long-period (LP) treatment group were done by using ANCOVA. Results The change of the mean of BMI ($-0.5{\pm}0.6kg/m^2$ vs $-1.4{\pm}0.8kg/m^2$, respectively; p=0.003) and OI ($-3.6{\pm}3.9%$ vs $-9.7{\pm}4.7%$, respectively; p<0.001) showed significant reduction both in SP (n=16) and LP treatment group (n=23). The mean height showed no significant difference in both groups. The mean weight of LP treatment group showed significant reduction compared to SP treatment group ($-0.2{\pm}1.3kg$ vs $-1.6{\pm}1.6kg$, respectively; p=0.006). Most of the children were compliant to the medication and no serious adverse events were found in two groups. Conclusions These findings emphasize that BMT is effective in the treatment of childhood obesity and it requires at least 45 days of treatment for the best result.

Keywords

References

  1. Christie D, Hudson L, Mathiot A, Cole TJ, Karlsen S, Kessel A, Kinra S, Morris S, Nazareth I, Sovio U, Wong IC, Viner RM. Assessing the efficacy of the Healthy Eating and Lifestyle Programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial. Trials. 2011;12:242. https://doi.org/10.1186/1745-6215-12-242
  2. Giordano U, Ciampalini P, Turchetta A, Santillil A, Calzolari F, Crino A, Pompei E, Alpert BS, Calzolari A. Cardiovascular hemodynamics: relationships with insulin resistance in obese children. Pediatr Cardiol. 2003;24:548-52. https://doi.org/10.1007/s00246-003-0368-8
  3. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA. 2003;289:1813-9. https://doi.org/10.1001/jama.289.14.1813
  4. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes. 2002;51:204-9. https://doi.org/10.2337/diabetes.51.1.204
  5. Williams J, Wake M, Hesketh K, Maher E, Waters E. Health-related quality of life of overweight and obese children. JAMA. 2005;293:70-6. https://doi.org/10.1001/jama.293.1.70
  6. Griffiths LJ, Parsons TJ, Hill AJ. Self-esteem and quality of life in obese children and adolescents: a systematic review. Int J Pediatr Obes. 2010;5:282-304. https://doi.org/10.3109/17477160903473697
  7. Ferraro KF, Kelley-Moore JA. Cumulative Disadvantage and Health: Long-Term Consequences of Obesity? Am Sociol Rev. 2003;68:707-29. https://doi.org/10.2307/1519759
  8. Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A, Torp-Pedersen C, Sharma AM, Ge H, Santoro D, Shepherd G, James P. Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in period. Obesity (Silver Spring). 2010;18:987-94. https://doi.org/10.1038/oby.2009.327
  9. Chanoine JP, Richard M. Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo. Int J Pediatr Obes. 2011;6:95-101. https://doi.org/10.3109/17477166.2010.519387
  10. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293:2873-83. https://doi.org/10.1001/jama.293.23.2873
  11. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab. 2007;92:4101-6. https://doi.org/10.1210/jc.2007-0826
  12. Aronne LJ, Halseth AE, Burns CM, Miller S, Shen LZ. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity (Silver Spring). 2010;18:1739-46. https://doi.org/10.1038/oby.2009.478
  13. Lee DH, Kim DG. The effects of Sobieum on decrease of body mass index (BMI) and obesity index of obese children. J Pediatr Korean Med. 2009;23(1):195-203.
  14. Park MJ, Min SJ, You KG, Jun KS, Yeam SR, Kwon YD. A case report of oriental medical treatment for obesity on overweight and obese children of broken home. J Oriental Rehab Med. 2012;22(4):147-56.
  15. You JH, Lee EJ, Kwak CK, Sohn EH, Koh BH, Song IB, Lee KS. Clinical trial of herbal formula on weight loss in obese korean children. Am J Chin Med. 2006;33(5): 713-22.
  16. Jung JH, Lee JY, Kim DK. Analysis of in-hospital child obese patients in Obesity clinic. J Pediatr Korean Med. 1997;11(1):149-58.
  17. Dept. of Sasang Constitutional Medicine. All colleges of oriental med. Sasang Constitutional Medicine. Jipmundang, Seoul, Korea, 2004:487.
  18. Jang YJ, Cho JH, Song BJ. Effect of Taeyeumjowee-Tang and electroacupuncture combined-therapy on obese patients. Journal of society of Korean medicine for obesity research. 2001;1(1):77-83.
  19. Lee SH, Chung SH, Shin HD. Effects of Taeyeumjowuitang (Taiyintiaowei-tang) on the correlation between heart rate variability and obesity parameters. J Oriental Rehab Med. 2005;15(4):47-54.
  20. Seo NJ, Nam DW, Lee EO, Shim BS, Ahn KS, Kim SH. Clinical study of Gamitaeeumjowi-tang for obese patients. Korean J Oriental Physiology & Pathology. 2008;22(2):446-52.
  21. Kim HJ, Ahn HS, Oh E, Kim YL. Effect of Taeeumjoweetang on the body composition, serum lipid level and antioxidant enzyme activity of obese female college students. J Sasang Constitut Med. 2011;23(3): 391-401.
  22. The Committee for Public Health Statistics, The Korean Pediatric Society. 2007 Korean National Growth Charts. 2007.
  23. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Accessed May, 17, 2010. Available from: URL: http://evs.nci.nih.gov/ftp1/CTCAE/About.html.
  24. Moon SH, Koh BH, Song IB. The effects of proliferation and differentiation on adipocyte 3T3-L1 by herbs and herbal prescriptions of Soeumin and Soyangin. Kyunghee University college of oriental medicine. 1997;21(1):453-77.
  25. Cho EM, Ryu EK. Effect of Fangfengtongsheng-san on obese patients. Journal of society of Korean medicine for obesity research. 2001;1 (1):57-62.
  26. Lee SY, Ryu HY. Effects of Ondamtang, samulansintang and Shihosogansan water extract on the obesity and stress. J of Oriental Neuropsychiatry. 1992;3(1):25-45.
  27. Lim DW, Song M, Park J, Park SW, Kim NH, Gaire BP, Choi HY, Kim HC. Anti-obesity effect of HT048, a herbal combination, in high fat diet-induced obese rats. Molecules. 2012;17(12):14765-77. https://doi.org/10.3390/molecules171214765
  28. Kwon MW, Kim IH, Park EJ, Kang BG. The clinical study of obese patient treated by Kamijowisengchungtang & Acupunture. J Korean Orient Pediatr. 2001;15(2): 43-51.
  29. Lee YJ, Ryu EK. The effect of management program of oriental medicine for obesity control on overweight and obese pediatrics. Journal of society of Korean medicine for obesity research. 2009;9(1):45-51.
  30. Cho YJ, Kim EJ, Song MY. Effect of I-razin in overweight children. Journal of society of Korean medicine for obesity research. 2010;10 (2):17-25.
  31. Haller CA, Benowitz NL. Adverse carduivascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000.343(25):1833-8. https://doi.org/10.1056/NEJM200012213432502
  32. Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. Journal of society of Korean medicine for obesity research. 2006;6(2):17-27.
  33. Kim HJ, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang (Ephedra sinica) prescription in obesity. Journal of society of Korean medicine for obesity research. 2007;7(2):27-37.
  34. Song YK, Lim HH. Clinical application of Ma Huang in the obesity treatment. Journal of society of Korean medicine for obesity research. 2007;7(1):1-7.
  35. Hsing LC, Lee TH, Son DH, Yeo JJ, Yang CS, Seo ES, Jang IS. Adverse effects of Ma-huang according to dose: A randomized double-blind placebo-controlled pilot study. Korean J Orient Inc Med. 2006;27(1):188-96.
  36. Yang DH, Kim CH, Jung JG, Jung HW, Choi CH. The effects of Taeyeumjowee-tang and Taeyeumjoweebaemahwang-tang on Obese rats. Kor J Herbology. 2010;25(3):103-9.
  37. Lison JF, Real-Montes JM, Torro I, Arguisuelas MD, Alvarez-Pitti J, Martinez-Gramage J, Aguilar F, Lurbe E. Exercise intervention in childhood obesity: a randomized controlled trial comparing hospital-versus home-based groups. Acad Pediatr. 2012;12:319-25.
  38. de Niet J, Timman R, Bauer S, van den Akker E, de Klerk C, Kordy H, Passchier J. Short Message Service Reduces Dropout in Childhood Obesity Treatment: A Randomized Controlled Trial. Health Psychol. 2012;31: 797-805. https://doi.org/10.1037/a0027498
  39. Kelishadi R, Malekahmadi M, Hashemipour M, Soghrati M, Soghrati M, Mirmoghtadaee P, Ghatrehsamani S, Poursafa P, Khavarian N. Can a trial of motivational lifestyle counseling be effective for controlling childhood obesity and the associated cardio metabolic risk factors? Pediatr Neonatol. 2012;53:90-7. https://doi.org/10.1016/j.pedneo.2012.01.005
  40. Koncsos P, Seres I, Harangi M, Pall D, Jozsa L, Bajnok L, Nagy EV, Paragh G. Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity. J Am Coll Nutr. 2011;30:333-9. https://doi.org/10.1080/07315724.2011.10719976
  41. Waters E, de Silva-Sanigorski A, Hall BJ, Brown T, Campbell KJ, Gao Y, Armstrong R, Prosser L. Summerbell CD. Interventions for preventing obesity in children. Cochrane Database Syst Rev. 2011;CD001871.
  42. West F, Sanders MR, Cleghorn GJ, Davies PS. Randomised clinical trial of a family-based lifestyle intervention for childhood obesity involving parents as the exclusive agents of change. Behav Res Ther. 2010;48:1170-9. https://doi.org/10.1016/j.brat.2010.08.008
  43. Freemark M. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care. 2007;30:395-402. https://doi.org/10.2337/dc06-1569

Cited by

  1. 인체를 대상으로 한 한의학적 비만 연구의 최신 국내 동향분석 vol.26, pp.1, 2013, https://doi.org/10.18325/jkmr.2016.26.1.49
  2. 소아비만의 치료에 대한 국내 임상연구 동향 vol.30, pp.3, 2013, https://doi.org/10.7778/jpkm.2016.30.3.108
  3. 한방소아과학회지에 출판된 임상연구논문에 대한 분석 vol.32, pp.4, 2013, https://doi.org/10.7778/jpkm.2018.32.4.141